Top cited articles

Acceptance rate


Time to first decision

6 days*

Time to first decision with review

59 days*

Acceptance to publication

15 days*

Impact Factor (JCR)




Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 28 February 2021
Ossato, Andrea; Tessari, Roberto; Trabucchi, Carlotta; et al

Petechial skin rash associated with CoronaVac vaccination: first cutaneous side effect report before phase 3 results
Cebeci, Filiz; Kartal, Ilkay

Incidence and prevalence of intravenous medication errors in the UK: a systematic review
Sutherland, Adam; Canobbio, Michela; Clarke, Janine; et al

Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19
Palanques-Pastor, Tomas; Lopez-Briz, Eduardo; Poveda Andres, Jose Luis

Assessment of the stability of citrate-buffered flucloxacillin for injection when stored in two commercially available ambulatory elastomeric devices: INfusor LV (Baxter) and Accufuser (Woo Young Medical): a study compliant with the NHS Yellow Cover Document (YCD) requirements
Allwood, Michael Charles; Stonkute, Donata; Wallace, Andrew; et al

Prevalence of drug interactions in hospitalised elderly patients: a systematic review
de Oliveira, Luciana Mello; Diel, Juliana do Amaral Carneiro; Nunes, Alessandra; et al

Usefulness of therapeutic drug monitoring of piperacillin and meropenem in routine clinical practice: a prospective cohort study in critically ill patients
Schoenenberger-Arnaiz, Joan Antoni; Ahmad-Diaz, Faten; Miralbes-Torner, Mar; et al

Physical stability of an all-in-one parenteral nutrition admixture for preterm infants upon mixing with micronutrients and drugs
Staven, Vigdis; Wang, Siri; Gronlie, Ingrid; Tho, Ingunn

CLEO: a multidimensional tool to assess clinical, economic and organisational impacts of pharmacists’ interventions
Vo, Ha Thi; Charpiat, Bruno; Chanoine, Sebastien; et al

Analysis of the third WHO Global Safety Challenge ‘Medication Without Harm’ patient-facing materials: exploratory descriptive study
Subakumar, Kisshante; Franklin, Bryony Dean; Garfield, Sara

Physicochemical stability of an admixture of lidocaine and ketamine in polypropylene syringe used in opioid-free anaesthesia
Beiler, Benoit; Barraud, Damien; Vigneron, Jean; et al

A prospective, observational study to evaluate adverse drug reactions in patients with COVID-19 treated with remdesivir or hydroxychloroquine: a preliminary report
Falcao, Fatima; Viegas, Erica; Carmo, Ines; et al

Cost-effectiveness analysis of infliximab, adalimumab, golimumab, vedolizumab and tofacitinib for moderate to severe ulcerative colitis in Spain
Trigo-Vicente, Cristina; Gimeno-Ballester, Vicente; Lopez-Del Val, Alejandro

The economic burden of metastatic breast cancer in Spain
Bermejo de las Heras, Begona; Ramon y Cajal, Javier Cortes; Galve Calvo, Elena; et al

Clinical pharmacy services in Germany: a national survey
Schulz, Claudia; Fischer, Andreas; Vogt, Winnie; et al

Do psychotropic drugs used during COVID-19 therapy have an effect on the treatment process?
Yalcin, Nadir; Ak, Sertac; Demirkan, Kutay

Improving the aseptic transfer procedures in hospital pharmacies. Part B: evaluation of disinfection methods for materials with a non-sterile surface
Boom, Frits A.; Le Brun, Paul P. H.; Boehringer, Stefan; et al

Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19
Moreno Diaz, Raquel; Amor Garcia, Miguel Angel; Teigell Munoz, Francisco Javier; et al

Effects of a multifaceted intervention in psychogeriatric patients: one-year prospective study
Hernandez, Marta; Mestres, Concepcion; Junyent, Jaume; et al

Occupational exposure to conventional antineoplastic drugs: can it be further limited?
Simon, Nicolas; Odou, Pascal; Decaudin, Bertrand; et al